Lysogene is a global leader in the basic research and clinical development of gene therapy for neurodegenerative disorders.

Our mission is to radically improve the health of patients suffering from incurable life threatening conditions. We do this by developing AAV vectors that have demonstrated their effectiveness in safely delivering genetic material to the central nervous system.